Professional Seasonal Analysis for Trading

Agios Pharmaceuticals, Inc. - Common Stock (AGIO)

Seasonality Analysis

Stocks 13 Years Analyzed

Agios Pharmaceuticals, Inc. - Common Stock Annual Seasonality Statistics

10.47%
Avg Annual Return
51.4%
Avg Monthly Win Rate
7/12
Positive Months
13
Years Analyzed

Agios Pharmaceuticals, Inc. - Common Stock Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January 3.01%
69%
Strong
February BEST 5.27%
54%
Moderate
March -1.22%
38%
Very Weak
April 2.94%
69%
Strong
May 4.47%
67%
Strong
June 2.05%
58%
Moderate
July -2.83%
46%
Weak
August -3.00%
46%
Weak
September 3.24%
46%
Weak
October -1.48%
38%
Very Weak
November 1.15%
54%
Moderate
December WORST -3.15%
31%
Very Weak

Agios Pharmaceuticals, Inc. - Common Stock 2026 vs Historical Pattern

Current Position
100
Historical Avg Position
43.41
Deviation
+56.59
Performance
Significantly Above Average

Agios Pharmaceuticals, Inc. - Common Stock Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for AGIO with overlay patterns, custom date ranges, and more.

Create Free Account

Agios Pharmaceuticals, Inc. - Common Stock Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Agios Pharmaceuticals, Inc. - Common Stock Seasonal Historical Performance

Historical Performance

See historical average returns for AGIO across multiple timeframes.

Create Free Account

About Agios Pharmaceuticals, Inc. - Common Stock (AGIO) Seasonality

Agios Pharmaceuticals, Inc. - Common Stock (AGIO) has been analyzed using 13 years of historical data to identify seasonal patterns. Classified under Stocks, Agios Pharmaceuticals, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.

The strongest month for Agios Pharmaceuticals, Inc. - Common Stock is historically February, with an average return of 5.27% and a win rate of 54%. Conversely, December tends to be the weakest month, averaging -3.15% return.

Looking at the full calendar year, Agios Pharmaceuticals, Inc. - Common Stock has an average annual return of 10.47% with an overall monthly win rate of 51.4%. Out of 12 months, 7 typically show positive average returns.

The seasonal pattern for Agios Pharmaceuticals, Inc. - Common Stock has a consistency score of 39.4 (Poor), based on 14 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Agios Pharmaceuticals, Inc. - Common Stock Seasonality FAQ

What is the best month to buy Agios Pharmaceuticals, Inc. - Common Stock (AGIO)?

Historically, February has been the best month for Agios Pharmaceuticals, Inc. - Common Stock, with an average return of 5.27% and a win rate of 54%. However, past performance does not guarantee future results.

What is the worst month for Agios Pharmaceuticals, Inc. - Common Stock (AGIO)?

Based on historical data, December has been the weakest month for Agios Pharmaceuticals, Inc. - Common Stock, with an average return of -3.15%. This is a historical observation and does not guarantee future results.

How reliable is AGIO seasonality data?

The seasonality analysis for Agios Pharmaceuticals, Inc. - Common Stock is based on 13 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Agios Pharmaceuticals, Inc. - Common Stock seasonality in my trading?

Use Agios Pharmaceuticals, Inc. - Common Stock (AGIO) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.